In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $0.68 in the prior trading day, Renalytix Plc ADR (NASDAQ: RNLX) closed at $0.69, up 2.50%. In other words, the price has increased by $2.50 from its previous closing price. On the day, 0.56 million shares were traded. RNLX stock price reached its highest trading level at $0.7166 during the session, while it also had its lowest trading level at $0.6506.
Ratios:
Our goal is to gain a better understanding of RNLX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 18, 2022, initiated with a Buy rating and assigned the stock a target price of $30.
On January 04, 2022, BTIG Research started tracking the stock assigning a Buy rating and target price of $24.
On October 04, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $28.Guggenheim initiated its Buy rating on October 04, 2021, with a $28 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNLX now has a Market Capitalization of 44190528 and an Enterprise Value of 72106608. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.34. Its current Enterprise Value per Revenue stands at 29.92 whereas that against EBITDA is -1.908.
Stock Price History:
The Beta on a monthly basis for RNLX is 3.07, which has changed by -0.69200003 over the last 52 weeks, in comparison to a change of 0.23099434 over the same period for the S&P500. Over the past 52 weeks, RNLX has reached a high of $4.04, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -21.31%, while the 200-Day Moving Average is calculated to be -45.85%.
Shares Statistics:
The stock has traded on average 1.90M shares per day over the past 3-months and 295560 shares per day over the last 10 days, according to various share statistics. A total of 46.89M shares are outstanding, with a floating share count of 46.30M. Shares short for RNLX as of 1713139200 were 673716 with a Short Ratio of 0.35, compared to 1710460800 on 894619.
Earnings Estimates
A detailed examination of Renalytix Plc ADR (RNLX) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.09, while EPS last year was -$0.28. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.31 and -$0.37 for the fiscal current year, implying an average EPS of -$0.34.
Revenue Estimates
2 analysts predict $950k in revenue for the current quarter. It ranges from a high estimate of $1.1M to a low estimate of $800k. As of the current estimate, Renalytix Plc ADR’s year-ago sales were $724kFor the next quarter, 2 analysts are estimating revenue of $1.45M. There is a high estimate of $1.6M for the next quarter, whereas the lowest estimate is $1.3M.
A total of 2 analysts have provided revenue estimates for RNLX’s current fiscal year. The highest revenue estimate was $4M, while the lowest revenue estimate was $3.2M, resulting in an average revenue estimate of $3.6M. In the same quarter a year ago, actual revenue was $3.4MBased on 2 analysts’ estimates, the company’s revenue will be $16.05M in the next fiscal year. The high estimate is $18M and the low estimate is $14.1M.
